BeiJing VDJBio Co.,LTD.

B311, No.5, Kaituo Rd., Haidian District, Beijing, 北京市, China

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

40.0%

Phase 2

40.0%

Phase 3

20.0%

Trial Status Distribution

Active, not recruiting

20.0%

Completed

40.0%

Enrolling By Invitation

20.0%

Recruiting

20.0%

Clinical Trials

Trials sponsored by this organization (5)

Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis

Phase 3

Enrolling By Invitation

interventional

Apr 2025615 participants

Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis

Phase 2

Completed

interventional

May 2022181 participants

A Study of Anti-IL-6R mAb Injection in Patients With iMCD

Phase 2

Active, not recruiting

interventional

Apr 202225 participants

Clinical Study of Recombinant Humanized CTLA-4-FC Fusion Protein Injection in Healthy Subjects

Phase 1

Recruiting

interventional

Sep 202146 participants

Clinical Study of Single Dose IL-6R mAb Injection in RA Patients

Phase 1

Completed

interventional

Mar 202140 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations